secwatch.observer — SEC 8-K summary
======================================

Issuer:     Solid Biosciences Inc. (SLDB)
CIK:        0001707502
Form:       8-K
Filed at:   2022-06-09T23:59:59+00:00
Accession:  0001193125-22-171086
Event type: other
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Solid Biosciences stockholders approve reverse stock split and authorized share increase
--------------------------------------------------------------------------------

- Elected Class I directors Huffines, Nagendran, Shah with ~65.9M votes each.
- Ratified PricewaterhouseCoopers as auditor for FY2022: 87.3M for, 226.9K against.
- Approved reverse stock split at ratio of 1:5 to 1:15, board to set exact ratio before 2023 annual meeting.
- Approved increase in authorized shares to 300M multiplied by 3x the reverse split ratio.
- Reverse split and share increase subject to board discretion; may be abandoned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522171086/0001193125-22-171086-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1707502/000119312522171086/d344917d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-171086

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer